Deep RNA sequencing of muscle tissue reveals absence of viral signatures in dermatomyositis
- PMID: 38205217
- PMCID: PMC10774810
- DOI: 10.17879/freeneuropathology-2024-5149
Deep RNA sequencing of muscle tissue reveals absence of viral signatures in dermatomyositis
Abstract
Objective: To explore a possible connection between active viral infections and manifestation of dermatomyositis (DM). Methods: Skeletal muscle biopsies were analyzed from patients diagnosed with juvenile (n=10) and adult (n=12) DM. Adult DM patients harbored autoantibodies against either TIF-1γ (n=7) or MDA5 (n=5). Additionally, we investigated skeletal muscle biopsies from non-diseased controls (NDC, n=5). We used an unbiased high-throughput RNA sequencing (HTS) approach to detect viral sequences. To further increase sequencing depth, a host depletion approach was applied. Results: In this observational study, no relevant viral sequences were detected either by native sequencing or after host depletion. The absence of detectable viral sequences makes an active viral infection of the muscle tissue unlikely to be the cause of DM in our cohorts. Discussion: Type I interferons (IFN) play a major role in the pathogenesis of both juvenile and adult DM. The IFN response is remarkably conserved between DM subtypes classified by specific autoantibodies. Certain acute viral infections are accompanied by a prominent type I IFN response involving similar downstream mechanisms as in DM. Aiming to elucidate the pathogenesis of DM in skeletal muscle tissue, we used deep RNA sequencing and a host depletion approach to detect possible causative viruses.
Keywords: Dermatomyositis (DM); Interferon (IFN); Next generation sequencing; Viral signature.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

Similar articles
-
NanoString technology distinguishes anti-TIF-1γ+ from anti-Mi-2+ dermatomyositis patients.Brain Pathol. 2021 May;31(3):e12957. doi: 10.1111/bpa.12957. Brain Pathol. 2021. PMID: 34043263 Free PMC article.
-
[Comparison of clinical and immunological features between clinically amyopathic dermatomyositis and typical dermatomyositis].Beijing Da Xue Xue Bao Yi Xue Ban. 2020 Dec 18;52(6):1001-1008. doi: 10.19723/j.issn.1671-167X.2020.06.003. Beijing Da Xue Xue Bao Yi Xue Ban. 2020. PMID: 33331305 Free PMC article. Chinese.
-
The relationship between type 1 IFN and vasculopathy in anti-MDA5 antibody-positive dermatomyositis patients.Rheumatology (Oxford). 2019 May 1;58(5):786-791. doi: 10.1093/rheumatology/key386. Rheumatology (Oxford). 2019. PMID: 30541137
-
Pathogenesis of Anti-melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis: A Concise Review With an Emphasis on Type I Interferon System.Front Med (Lausanne). 2022 Jan 24;8:833114. doi: 10.3389/fmed.2021.833114. eCollection 2021. Front Med (Lausanne). 2022. PMID: 35141258 Free PMC article. Review.
-
The efficacy and safety of tofacitinib in anti-melanoma differentiation-associated gene 5 antibody positive dermatomyositis associated interstitial lung disease: a systematic review and meta-analysis.Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241294000. doi: 10.1177/17534666241294000. Ther Adv Respir Dis. 2024. PMID: 39480695 Free PMC article.
References
-
- Allenbach Y, Leroux G, Suarez-Calvet X, Preusse C, Gallardo E, Hervier B, Rigolet A, Hie M, Pehl D, Limal N et al (2016) Dermatomyositis With or Without Anti-Melanoma Differentiation-Associated Gene 5 Antibodies: Common Interferon Signature but Distinct NOS2 Expression. Am J Pathol 186: 691-700. DOI: 10.1016/j.ajpath.2015.11.010 - DOI - PubMed
-
- Asplund M, Kjartansdottir KR, Mollerup S, Vinner L, Fridholm H, Herrera JAR, Friis-Nielsen J, Hansen TA, Jensen RH, Nielsen IB et al (2019) Contaminating viral sequences in high-throughput sequencing viromics: a linkage study of 700 sequencing libraries. Clin Microbiol Infect 25: 1277-1285. DOI: 10.1016/j.cmi.2019.04.028 - DOI - PubMed
LinkOut - more resources
Full Text Sources